In agreement with our results, CD8+ T cell infiltration has been shown to be an independent positive prognostic factor that is strongly associated with better outcomes in patients with lung cancer (65), colorectal cancer (66), esophageal cancer (67), and other cancers. The gene discussed is CD8A; the disease is lung carcinoma.